Conjunctivitis, Bacterial: Clinical Trials

2 trials for Conjunctivitis, Bacterial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Withdrawn 2
Phase 31Withdrawn 1

Follow Conjunctivitis, Bacterial: new trials by email Literature Review of Conjunctivitis, Bacterial trials Research Report on Conjunctivitis, Bacterial

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nepal Elimination of Trachoma Study
Azithromycin - Trachoma
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2014-08-012015-05-21
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
AL-15469A 0.5% and AL-6515 0.3% Ophthalmic Suspension, AL-15469A 0.5%, AL-6515 0.3% - Bacterial Conjunctivitis
Phase 2WithdrawnAlcon Research2011-01-012011-12-01

Narrower conditions

Trachoma (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Conjunctival Diseases (2)  ·  Conjunctivitis (2)  ·  Eye Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Bacterial (2)  ·  Infections (2)  ·  Chlamydia Infections (1)  ·  Chlamydiaceae Infections (1)  ·  Corneal Diseases (1)  ·  Gram-Negative Bacterial Infections (1)

Interventions

Azithromycin (1)

Sponsors

Alcon Research (1)  ·  University of California, San Francisco (1)

Countries

Nepal (1)

Top investigators

Bruce D Gaynor, MD (1)

NIH funding

K23EY019881 (1)